聯合健康集團UNH
紐約證券 · USD
331.63
-2.57
(-0.77%)
收盤 12/18 04:59 (UTC+8)
盤後
330.40
330.40
(-0.37%)
12/18 04:59 (UTC+8)
聯合健康集團UNH
331.63
-2.57
(-0.77%)
財務數據
損益表
- 929.03
- 923.61
- 944.27
- 997.96
- 988.55
- 1008.20
- 1008.07
- 1095.75
- 1116.16
- 1131.61
- 1.06
- -0.58
- 2.24
- 5.69
- -0.94
- 1.99
- -0.01
- 8.70
- 1.86
- 1.38
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 113,161,000 | 111,616,000 | 109,575,000 | 100,807,000 | 100,820,000 | 98,855,000 | 99,796,000 | 94,427,000 | 92,361,000 | 92,903,000 |
營業成本 | 92,524,000 | 91,604,000 | 73,411,000 | 67,035,000 | 65,957,000 | 65,458,000 | 65,735,000 | 62,231,000 | 59,550,000 | 60,268,000 |
營業毛利 | 20,637,000 | 20,012,000 | 36,164,000 | 33,772,000 | 34,863,000 | 33,397,000 | 34,061,000 | 32,196,000 | 32,811,000 | 32,635,000 |
營業費用 | 16,322,000 | 14,862,000 | - | - | - | - | 26,130,000 | 24,507,000 | 24,285,000 | 24,578,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | - | - | - | - | - | - | - | - | - | - |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 15,223,000 | 13,778,000 | 27,045,000 | 25,999,000 | 26,155,000 | 25,522,000 | 26,130,000 | 24,507,000 | 24,285,000 | 24,578,000 |
營業利益 | 4,315,000 | 5,150,000 | 9,119,000 | 7,773,000 | 8,708,000 | 7,875,000 | 7,931,000 | 7,689,000 | 8,526,000 | 8,057,000 |
其他收入及費用 | - | - | -15,000 | 21,000 | -20,000 | -1,225,000 | -7,086,000 | - | - | - |
利息費用 | 1,003,000 | 1,027,000 | 998,000 | 1,003,000 | 1,074,000 | 985,000 | 844,000 | 830,000 | 834,000 | 828,000 |
稅前純益 | 3,229,000 | 4,082,000 | 8,106,000 | 6,791,000 | 7,614,000 | 5,665,000 | 1,000 | 6,859,000 | 7,692,000 | 7,229,000 |
所得稅 | 686,000 | 510,000 | 1,632,000 | 1,007,000 | 1,356,000 | 1,244,000 | 1,222,000 | 1,184,000 | 1,654,000 | 1,572,000 |
稅後純益 | 2,348,000 | 3,406,000 | 6,292,000 | 5,543,000 | 6,055,000 | 4,216,000 | -1,409,000 | 5,455,000 | 5,841,000 | 5,474,000 |
基本每股稅後盈餘(元) | 2.59 | 3.76 | 6.91 | 6.06 | 6.51 | 4.58 | -1.53 | 5.90 | 6.31 | 5.89 |
稀釋每股稅後盈餘(元) | 2.59 | 3.74 | 6.85 | 5.98 | 6.51 | 4.55 | -1.53 | 5.85 | 6.24 | 5.82 |
基本平均股數(千股) | 905673.00 | 905000.00 | 910000.00 | 915000.00 | 930107.00 | 921000.00 | 920000.00 | 924000.00 | 926000.00 | 930000.00 |
稀釋平均股數(千股) | 908000.00 | 910000.00 | 918000.00 | 927000.00 | 930107.00 | 928000.00 | 922000.00 | 935000.00 | 936000.00 | 940000.00 |
還原基本每股稅後盈餘(元) | 2.59 | 3.76 | 6.91 | 6.06 | 6.51 | 4.58 | -1.53 | 5.90 | 6.31 | 5.89 |
還原稀釋每股稅後盈餘(元) | 2.59 | 3.74 | 6.85 | 5.98 | 6.51 | 4.55 | -1.53 | 5.85 | 6.24 | 5.82 |
還原基本平均股數(千股) | 905,673 | 905,000 | 910,000 | 915,000 | 930,107 | 921,000 | 920,000 | 924,000 | 926,000 | 930,000 |
還原稀釋平均股數(千股) | 908,000 | 910,000 | 918,000 | 927,000 | 930,107 | 928,000 | 922,000 | 935,000 | 936,000 | 940,000 |
EBITDA(千元) | 5,136,000 | 6,027,000 | 9,983,000 | 8,594,000 | 9,526,000 | 7,465,000 | 1,654,000 | 8,443,000 | 9,336,000 | 8,895,000 |